Diabetes linked to higher risk of sudden cardiac death – especially for younger people
News • Cardiovascular health
New study finds the increase is especially pronounced in younger age groups
© Sebastian Kaulitzki – stock.adobe.com
A recent study published in the European Heart Journal reveals a concerning trend: individuals with diabetes face a significantly elevated risk of sudden cardiac death, particularly among younger adults. This finding highlights the urgent need for proactive measures to mitigate this health risk.
The research, led by Dr. Tobias Skjelbred from Copenhagen University Hospital, Rigshospitalet, Denmark, analyzed data from the entire Danish population in 2010. By examining 54,028 deaths, the study identified 6,862 cases of sudden cardiac death. The researchers then compared these cases with records of diabetes status, revealing startling disparities in risk.
The study found that sudden cardiac death was 3.7 times more common among individuals with type 1 diabetes and 6.5 times more common for those with type 2 diabetes, compared to the general population. However, the difference in risk was most pronounced in younger adults, with people under 50 who have diabetes facing a seven times higher risk of sudden cardiac death.
Furthermore, the research indicated that individuals with diabetes have a shorter life expectancy on average, with a 14.2-year reduction for those with type 1 diabetes and a 7.9-year reduction for those with type 2 diabetes. Sudden cardiac death contributed significantly to these shortened life expectancies, accounting for 3.4 years lost in type 1 diabetes cases and 2.7 years in type 2 diabetes cases.
Dr. Skjelbred emphasizes the importance of collaboration between individuals with diabetes and their healthcare providers to mitigate cardiovascular risk. While sudden cardiac death is challenging to predict and prevent, these findings underscore the need for proactive management of diabetes to reduce the risk of cardiovascular complications.
The study also highlights the limitations of focusing solely on data from 2010, before the widespread use of newer glucose-lowering therapies. This limitation prevents the assessment of how these treatments may have influenced sudden cardiac death in more recent years.
Looking ahead, researchers suggest that identifying subgroups within the diabetes population who might benefit from preventive strategies is crucial. This could involve the development of personalized treatment interventions aimed at preventing sudden cardiac arrest (SCA) and improving SCA treatment outcomes.
In an accompanying editorial, Dr. Hanno Tan from Amsterdam UMC, University of Amsterdam, Netherlands, and colleagues emphasize the ongoing challenges in preventing and treating sudden cardiac death. They highlight the elevated incidence of SCA in diabetics compared to the general population and the importance of quantifying the extent of life expectancy loss due to diabetes and the contribution of SCA to this loss.
The editorial also discusses the potential of developing autonomous systems to detect SCA and call emergency services, particularly for type 1 diabetes patients, who experience a higher proportion of unwitnessed SCA events. These advancements could significantly reduce the burden of SCA in diabetes patients through personalized treatment interventions.
